Nacuity Pharmaceuticals, Inc. — Form D/A

Nacuity Pharmaceuticals, Inc. of FORT WORTH, TX, a company, filed a Form D amendment with the SEC on 2017-07-20. The offering totals $10.0M, of which $9.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Isaac Michael BlechDirectorNew York, NY
Dr. Gerald D CagleDirectorFort Worth, TX
Richard Michael Chin, M.D.DirectorSan Francisco, CA
William Halden ConnerDirectorFort Worth, TX
Sanford J HillsbergDirectorLos Angeles, CA
David J WohlbergDirectorLos Angeles, CA
William Halden ConnerExecutive OfficerFort Worth, TX
Charles Michael LieserExecutive OfficerFort Worth, TX
G. Michael Wall, Ph.D.Executive OfficerFort Worth, TX
Michael WallExecutive OfficerFort Worth, TX
Robin SteeleDirectorFort Worth, TX
David WohlbergDirectorFort Worth, TX
David WohlbergExecutive OfficerFort Worth, TX
Rusty KelleyDirectorFort Worth, TX
Gerald CagleDirectorFort Worth, TX
Jami KernExecutive OfficerFort Worth, TX
Benjamin YerxaDirectorFort Worth, TX
Emmett Cunningham, Jr.DirectorFort Worth, TX
Halden ConnerDirectorFort Worth, TX
Halden ConnerExecutive OfficerFort Worth, TX
Charles LieserExecutive OfficerFort Worth, TX
Robert RuffoloDirectorBoston, MA
Robin SteelDirectorFort Worth, TX

Other filings by this issuer (5)

FiledFormOfferingSold
2025-12-30D$30.0M$8.4M
2022-01-03D/A$17.4M$11.6M
2021-03-30D$11.0M$3.2M
2017-06-27D$10.0M$7.3M
2016-12-08D$2.5M$2.0M

More